# Safety, Tolerability, and Pharmacokinetics of Multiple-Dose RFUS-949 in Healthy Chinese Participants

> **NCT07676357** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 28 (estimated)

## Conditions studied

- Acute and Chronic Pain

## Interventions

- **DRUG:** RFUS-949
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07676357
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-22
- **Primary completion:** 2026-06-28
- **Final completion:** 2026-08-01
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07676357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07676357, "Safety, Tolerability, and Pharmacokinetics of Multiple-Dose RFUS-949 in Healthy Chinese Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07676357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*